Immunogene therapy for cancer: The current situation and a way forward

S. Hazama, K. Yoshimura, M. Oka

Research output: Contribution to journalArticle

Abstract

Immunogene-based therapies for cancer include ex vivo and in vivo cytokine gene transfer, as well as costimulatory molecule gene transfer. The goal is that of increasing the immunogenicity of poorly or nonimmunogenic tumors and of producing an effective antitumor vaccine. A review of clinical trials indicates that these treatments can mediate tumor regression with acceptably low toxicity. Important areas for future research include increasing the transduction efficiency of vectors, enhancing vector targeting and specificity, and identifying synergies between several cytokines and costimulatory molecules. The immunogene therapies promise a new approach for active immunotherapy of cancer and for the isolation of effector cell populations for use in adoptive immunotherapy protocols.

Original languageEnglish (US)
Pages (from-to)382-386
Number of pages5
JournalBiotherapy
Volume12
Issue number3
StatePublished - 1998
Externally publishedYes

Fingerprint

Neoplasms
Cytokines
Adoptive Immunotherapy
Active Immunotherapy
Cell Separation
Therapeutics
Genes
Vaccines
Clinical Trials
Population

Keywords

  • Cancer
  • Cytokines
  • Immunogene therapy
  • Vaccination

ASJC Scopus subject areas

  • Cancer Research
  • Immunology and Allergy

Cite this

Hazama, S., Yoshimura, K., & Oka, M. (1998). Immunogene therapy for cancer: The current situation and a way forward. Biotherapy, 12(3), 382-386.

Immunogene therapy for cancer : The current situation and a way forward. / Hazama, S.; Yoshimura, K.; Oka, M.

In: Biotherapy, Vol. 12, No. 3, 1998, p. 382-386.

Research output: Contribution to journalArticle

Hazama, S, Yoshimura, K & Oka, M 1998, 'Immunogene therapy for cancer: The current situation and a way forward', Biotherapy, vol. 12, no. 3, pp. 382-386.
Hazama, S. ; Yoshimura, K. ; Oka, M. / Immunogene therapy for cancer : The current situation and a way forward. In: Biotherapy. 1998 ; Vol. 12, No. 3. pp. 382-386.
@article{ed044f023e3d472eabfad3cec4bcc726,
title = "Immunogene therapy for cancer: The current situation and a way forward",
abstract = "Immunogene-based therapies for cancer include ex vivo and in vivo cytokine gene transfer, as well as costimulatory molecule gene transfer. The goal is that of increasing the immunogenicity of poorly or nonimmunogenic tumors and of producing an effective antitumor vaccine. A review of clinical trials indicates that these treatments can mediate tumor regression with acceptably low toxicity. Important areas for future research include increasing the transduction efficiency of vectors, enhancing vector targeting and specificity, and identifying synergies between several cytokines and costimulatory molecules. The immunogene therapies promise a new approach for active immunotherapy of cancer and for the isolation of effector cell populations for use in adoptive immunotherapy protocols.",
keywords = "Cancer, Cytokines, Immunogene therapy, Vaccination",
author = "S. Hazama and K. Yoshimura and M. Oka",
year = "1998",
language = "English (US)",
volume = "12",
pages = "382--386",
journal = "Biotherapy",
issn = "0914-2223",
publisher = "Japanese Society for Cancer Chemotherapy",
number = "3",

}

TY - JOUR

T1 - Immunogene therapy for cancer

T2 - The current situation and a way forward

AU - Hazama, S.

AU - Yoshimura, K.

AU - Oka, M.

PY - 1998

Y1 - 1998

N2 - Immunogene-based therapies for cancer include ex vivo and in vivo cytokine gene transfer, as well as costimulatory molecule gene transfer. The goal is that of increasing the immunogenicity of poorly or nonimmunogenic tumors and of producing an effective antitumor vaccine. A review of clinical trials indicates that these treatments can mediate tumor regression with acceptably low toxicity. Important areas for future research include increasing the transduction efficiency of vectors, enhancing vector targeting and specificity, and identifying synergies between several cytokines and costimulatory molecules. The immunogene therapies promise a new approach for active immunotherapy of cancer and for the isolation of effector cell populations for use in adoptive immunotherapy protocols.

AB - Immunogene-based therapies for cancer include ex vivo and in vivo cytokine gene transfer, as well as costimulatory molecule gene transfer. The goal is that of increasing the immunogenicity of poorly or nonimmunogenic tumors and of producing an effective antitumor vaccine. A review of clinical trials indicates that these treatments can mediate tumor regression with acceptably low toxicity. Important areas for future research include increasing the transduction efficiency of vectors, enhancing vector targeting and specificity, and identifying synergies between several cytokines and costimulatory molecules. The immunogene therapies promise a new approach for active immunotherapy of cancer and for the isolation of effector cell populations for use in adoptive immunotherapy protocols.

KW - Cancer

KW - Cytokines

KW - Immunogene therapy

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=0031898744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031898744&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031898744

VL - 12

SP - 382

EP - 386

JO - Biotherapy

JF - Biotherapy

SN - 0914-2223

IS - 3

ER -